## Synthesis
- 
## Source [^1]
- (DLQI) a validated questionnaire designed by Finlay in 1994 to assess the impact of skin diseases on psychological and social wellbeing. It is the most common quality of life tool used as an endpoint in dermatology clinical trials. DLQI scores of more than 10 (indicating a severe impact on life) are required before biological treatments for psoriasis may be administered in the UK.
## References

[^1]: [[Home Page - Concise Medical Dictionary 10th Edition by Oxford Reference]]